Medical Devices News and Research

RSS

Abbott to acquire Evalve for $410 million

Abbott announced today a definitive agreement to acquire the outstanding equity of Evalve, Inc., the global leader in the development of devices for minimally invasive repair of cardiac mitral valves.

10 Sep 2009

Labs grumble over co-pays, new fees for Medicare lab work

Roll Call reports that big labs — including ones like Quest Diagnostics — are unhappy with a Senate Finance Committee proposal to increase taxes for labs that perform Medicare services.

10 Sep 2009

Capsule launches new Enterprise Medical Device Connectivity Solution

Capsule (www.capsuletech.com), the leading provider of medical device connectivity, today announces the release of their new Enterprise Medical Device Connectivity Solution enabled by the Capsule Neuron™.

10 Sep 2009

RTS signs vendor financing agreement with MAKO Surgical

Relational Technology Solutions (RTS), the fifth largest independent finance company in the U.S., today announced that it has entered into a vendor financing agreement with MAKO Surgical Corp.

10 Sep 2009

IBM study reveals the need for smart drug manufacturer supply chain systems

Reducing the risk of counterfeit drugs and contaminated medications amidst the complexity of global manufacturing are among the top concerns of the pharmaceutical and life sciences industries today, according to a new IBM (NYSE: IBM) study. More than 50 percent of executives polled say their companies fail to respond quickly enough to pandemics and other emergencies because of lapses in their supply chain.

10 Sep 2009

Wright Medical Group launches ORTHOLOC Polyaxial Locked Plating System

Wright Medical Group, Inc., a global orthopaedic medical device company, today announced the launch of the ORTHOLOC Polyaxial Locked Plating System for surgical treatment of foot and ankle fractures.

10 Sep 2009

A voluntary recall program announced by CONMED Linvatec

CONMED Corporation's (NASDAQ: CNMD) CONMED Linvatec unit announced today a voluntary recall for certain model numbers of the PRO5 & PRO6 series battery handpieces manufactured prior to May 31, 2008, and certain lots of the MC5057 Universal Cable manufactured prior to December 1, 2006 used with certain of CONMED Linvatec's electric powered handpieces.

9 Sep 2009

Ceragenix awarded $2.87M NIH grant to develop a drug for treating Clostrdium difficile and Shigella

Ceragenix Pharmaceuticals, Inc. (“Ceragenix”) (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that the National Institutes of Health (“NIH”) has awarded a $2.87 million grant to fund the pre clinical development of a Ceragenin™based oral drug to treat two common and potentially deadly gastrointestinal infections: Clostrdium difficile and Shigella.

9 Sep 2009

Syneron Medical to merge with Candela Corporation

Syneron Medical Ltd. (NASDAQ:ELOS) and Candela Corporation (NASDAQ:CLZR) announced today that they have entered into a definitive agreement to combine the companies in an all stock transaction. This strategic combination, unanimously approved by the Boards of Directors of both companies, will create a global leader in medical aesthetic devices. The transaction is expected to be completed by year-end 2009.

9 Sep 2009

APCER comments on FDA's decision regarding electronic submission of reports

APCER Pharma Solutions, Inc. (“APCER”) President and CEO Suneet Walia commented on the US Food and Drug Administration’s (FDA) proposed rules to amend postmarket safety reporting regulations for three of its centers, to require manufacturers and other facilities subject to current reporting requirements to submit their reports electronically.

9 Sep 2009

Baucus sends $900 billion health care proposal to 'gang of six'

Sen. Max Baucus, D-Mont., chairman of the Senate Finance Committee, has sent his "gang of six" colleagues on the Senate Finance Committee a health overhaul proposal that would cost under $900 billion.

9 Sep 2009

MHLW to grant regulatory approval for KCI to enter Japan market

Kinetic Concepts, Inc. (NYSE: KCI) announced today that it has been informed by the Pharmaceutical and Medical Devices Agency (PMDA) in Japan that in October the Ministry of Health, Labor and Welfare (MHLW) will grant regulatory approval for KCI to begin market development activities in Japan for its innovative V.A.C.® Therapy product.

9 Sep 2009

Baucus plan details released; Grassley says Bipartisan bill 'up in the air'

According to CQ Politics, Chairman Max Baucus' is circulated a proposal to the Finance Committee Gang Of Six over the weekend that would "establish a system of consumer-owned insurance cooperatives in lieu of a ... 'public plan' and would expand Medicaid to millions more Americans."

9 Sep 2009

Haemonetics acquires SEBRA's blood collection and processing business

Haemonetics Corporation, a global blood management solutions company, and Engineering and Research Associates Inc. (known as "SEBRA(R)"), a leading provider of blood and medical manufacturing technologies, announced today that Haemonetics has acquired the assets of SEBRA's blood collection and processing business for $12.5 million cash. The acquisition is expected to close within the next several weeks.

8 Sep 2009

Capsule expands marketing program

After extensive planning, strategizing, and consulting, Capsule, the leading provider of medical device connectivity, has announced that they are expanding their marketing program to include social media. From Twitter, to Capsule's very own Facebook fan page, Capsule is ready to engage and gain new insights in order to better serve the clinical and HIT community.

8 Sep 2009

Axel Ullrich receives the 2009 Dr. Paul Janssen Award for Biomedical Research

Johnson & Johnson today honored the career achievements of Axel Ullrich, Ph.D., with the 2009 Dr. Paul Janssen Award for Biomedical Research. Dr. Ullrich received this award for his scientific discoveries that led to innovative new drugs including Herceptin((R)) (trastuzumab)*, a personalized medicine therapy, which was the first to target a specific type of breast cancer.

8 Sep 2009

Iterative in situ click chemistry creates antibody-like protein-capture agents

Chemists at the California Institute of Technology (Caltech) and The Scripps Research Institute (SRI) have developed an innovative technique to create cheap but highly stable chemicals that have the potential to take the place of the antibodies used in many standard medical diagnostic tests. James R. Heath, Ph.D., principal investigator of the Nanosystems Biology Cancer Center at Caltech, one of eight Centers of Cancer Nanotechnology Excellence, and K. Barry Sharpless, Ph.D., SRI, and their colleagues describe the new technique in the journal Angewandte Chemie International Edition.

7 Sep 2009

SoftScan clinical results from a breast cancer treatment monitoring study to be presented at IEEE International Conference

ART Advanced Research Technologies Inc. (ART) (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce that Dr. Gregory Czarnota, MD, PhD, Radiation Oncologist at Odette Cancer Centre, Sunnybrook Health Sciences Centre, will be presenting SoftScan® clinical results from a breast cancer treatment monitoring study, at the IEEE Engineering in Medicine and Biology Society 31st Annual International Conference in Minneapolis, Minn.

5 Sep 2009

Many high health costs remain mysterious, including the cost of reform

Health care's high costs are a main reason lawmakers are taking on health reform, but it's also a challenge to identify and target the many reasons care is so expensive. NPR takes a look at medical devices, like plastic tubes and scalpels, that boast surprisingly big price tags. A $2,000 dollar metal stent must be tiny and flexible, a $60 plastic catheter must bend in exactly the right way and "the market is still sorting itself out" on the appropriate price of relatively new specialty scalpels used for heart surgery (Joffe-Walt 9/4).

5 Sep 2009

RAC certification for 263 regulatory professionals

The Regulatory Affairs Professionals Society (RAPS) has announced that 263 regulatory professionals achieved Regulatory Affairs Certification (RAC) during the most recent exam period. The RAC credential is administered by RAPS and is the only certification specifically for regulatory professionals in the healthcare product sector.

5 Sep 2009